Zaffar Rizvi
Psychiatry · Rockford, ILNPI 1730257056
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 299 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 299 payments — averaging $20.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- Alkermes, Inc.$991
- Lundbeck LLC$929
- AbbVie$733
- Sunovion Pharmaceuticals Inc.$563
- Johnson & Johnson$466
- plus $2K from 17 others
What the payments were for
- Food & beverage$6,05897%
- Education$2053%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 40 | $1,026 |
| Alkermes, Inc. | 25 | $991 |
| Lundbeck LLC | 61 | $929 |
| AbbVie(2 entities) | 30 | $733 |
| Sunovion Pharmaceuticals Inc. | 34 | $563 |
| Johnson & Johnson | 23 | $466 |
| Teva Pharmaceuticals USA, Inc. | 12 | $300 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $298 |
| Eisai Inc. | 11 | $199 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $193 |
| Neurocrine Biosciences, Inc. | 7 | $187 |
| Vanda Pharmaceuticals Inc. | 5 | $102 |
| Noven Therapeutics, LLC | 5 | $91 |
| Bausch Health US, LLC | 2 | $49 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Noven Pharmaceuticals, Inc. | 1 | $18 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Indivior Inc. | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
| Merck | 1 | $12 |
| Shire North American Group Inc | 1 | $12 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$1,726
- ARISTADA INITIO$432
- VRAYLAR$215
- ABILIFY MAINTENA$209
- INVEGA SUSTENNA$125
- INGREZZA$102
How this compares
$6,263 in reported general payments places this provider in the 90th percentile of 1,344 psychiatry providers in Illinois.
Other psychiatry in Rockford
- Jose MontesRockford$882K
- Shahina JafryRockford$82K
- Babatunde OgundipeRockford$37K
- Uma SrivastavaRockford$23K
- Raymond GarciaRockford$16K
- Michael FeldNorthbrook$1.1M
- Mitchell GlaserChicago$752K
- Roukan JazayerliOrland Park$597K
- Ming XuBourbonnais$505K
- Peter WeidenChicago$440K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.